Loading
Latest filing published 04 May 2018 for Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.), €19k.
No signal scores available.
Richard Theodore Ho discloses dealings in Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) to SEDI. The record holds 2 filings, for trades running from 12 June 2017 to 3 May 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 4 May 2018 with a transaction (€19k) in Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations